Sage Journals: Discover world-class research

Open access

Review article

First published 2024

Zolbetuximab for Claudin18.2-positive gastric or gastroesophageal junction cancer

Yohei Kubota, Kohei Shitara

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022

A population-based study in resected esophageal or gastroesophageal junction cancer aligned with CheckMate 577

Marieke Pape, Pauline A.J. Vissers, Laurens V. Beerepoot [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023

Understanding the Challenges Faced by Esophageal and Gastroesophageal Junction Cancer Survivors

Erin McGillivray, Rishi Jain, Chethan Ramamurthy [...]

Journal of Patient Experience

Free access

Research article

First published 2016-3

Comparative Investigation of Postoperative Complications in Patients With Gastroesophageal Junction Cancer Treated With Preoperative Chemotherapy or Surgery Alone

M. P. Achiam, L. B. Jensen, H. Larsson [...]

Scandinavian Journal of Surgery

Retricted access

Research article

First published 2012-11

Surgical Outcomes for Cancer at the Gastroesophageal Junction

Sohei Matsumoto, Tomoyoshi Takayama, Kohei Wakatsuki [...]

The American Surgeon™

Open access

Research article

First published 2024

Immune Checkpoint Inhibitor Plus Chemotherapy as First-Line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer: A Systematic Review and Meta-Analysis

Lianghui Zhang, Lingli Huang, Zhixian Liu [...]

Technology in Cancer Research & Treatment

Open access

Research article

First published 2024-7

Efficacy and safety of anti-programmed death-1 antibody-based combination therapy in advanced or metastatic gastric or gastroesophageal junction cancer in Chinese patients: A real-world study

Yifan Gao, Haoqian Li, Lei Qiu [...]

Science Progress

Open access

Research article

First published 2023

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric cancer,gastroesophageal junction cancer,and esophageal adenocarcinoma: a cost-effectiveness analysis

Xueqiong Cao, Mingming Zhang, Na Li [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023

Immune checkpoint inhibitors plus chemotherapy for HER2-negative advanced gastric/gastroesophageal junction cancer: a cost-effectiveness analysis

Youwen Zhu, Kun Liu, Hong Zhu [...]

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2010-5

Markers of angiogenesis and epidermal growth factor receptor signalling in patients with pancreatic and gastroesophageal junction cancer

Kristoffer Staal Rohrberg, Birgit Guldhammer Skov, Ulrik Lassen [...]

Cancer Biomarkers

Search results